Stay updated on Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not be about the study, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page no longer displays a government funding/operating status notice. Core study information, contacts, and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedThe updates are layout and formatting adjustments to the study page without changes to core trial data. There are no modifications to inclusion criteria, primary/secondary outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference3%

- Check78 days agoChange DetectedUpdated revision to v3.1.0 with added contact details (phone and email); previous version v3.0.2 is removed.SummaryDifference0.1%

- Check93 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.